tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Drug License Suspensions in Maharashtra

Story Highlights
MedPlus Subsidiary Faces Drug License Suspensions in Maharashtra

Claim 70% Off TipRanks Premium

An update from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) is now available.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for the Drug License of a store in Maharashtra. The suspensions, issued by the Food & Drug Administration in Amravati and Nagpur, are expected to result in a potential revenue loss of approximately Rs 10.17 lacs. This development may impact the company’s financial operations and highlights regulatory challenges in maintaining compliance with the Drugs and Cosmetics Act.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and services. The company is known for its chain of retail pharmacies across India, catering to a wide market with a focus on accessibility and affordability of healthcare products.

Average Trading Volume: 21,584

Technical Sentiment Signal: Buy

Current Market Cap: 96.4B INR

For an in-depth examination of MEDPLUS stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1